Central serous chorioretinopathy (CSC) and corticosteroids;Chorioretinopathia serosa centralis (CSC) und kortikosteroide

Klinische Monatsblatter fur Augenheilkunde

Volumn 225, Issue 5, 2008, Pages 370-375

  Stoffelns, Bernhard M ^a   Kramann, C ^a   Schoepfer, K ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Central serous chorioretinopathy; Corticosteroids; CSC; Systemic disorders

Indexed keywords

AZATHIOPRINE; BETAMETHASONE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DEXAMETHASONE; FLUOCORTIN; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE; TRIAMCINOLONE;

ADULT; ARTICLE; CENTRAL SEROUS RETINOPATHY; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DRUG EFFECT; DRUG WITHDRAWAL; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; LOW DRUG DOSE; MALE; RECURRENT DISEASE;

ADRENAL CORTEX HORMONES; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; CHOROID DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; RETINAL DISEASES; THERAPEUTICS;

EID: 47649110763     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1027271     Document Type: Article

References (29)

1. Basti CP. Regulation of cation transport by low doses of glucocorticoids. J Clin Invest 1987; 80: 848-56
2. Bouzas EA, Karadimas P, Pournaras CJ. Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol 2002; 47: 431-448
3. Castro-Correia J, Coutinho MF, Rosas V et al. Long-term follow-up of central serous retinopathy in 150 patients. Doc Ophthalmol 1992; 81: 379-86
4. Chaine G, Haouat M, Menard-Molcard C. Central serous chorioretinopathy and systemic steroid therapy. J Fr Ophthalmol 2001; 24: 139-46
5. Ciardella AP, Borodoker N, Costa DLL et al. The expanding clinical spectrum of central serous chorioretinopathy. Comp Ophthalmol Update 2003; 4: 71-84
6. Eckstein MB, Spalton DJ, Holder G. Visual loss from central serous retinopathy in systemic lupus erythematosus. Br J Ophthalmol 1993; 77: 607-609
7. Fastenberg DM, Ober RR. Central serous choroidopathy in pregnancy. Arch Ophthalmol 1983; 101: 1055-1058
8. Fraunfelder FT, Meyer SM. Drug-induced ocular side-effects and drug interactions. 3. ed. Philadelphia: Lea and Febiger, 1989: 386-427
9. Gass JD et al. Pathogenesis of disciform detachment of the neuroepithelium. Am J Ophthalmol 1967; 63 (Suppl): 1-139
10. Gass JD. Central serous chorioretinopathy and white subretinal exudation during pregnancy. Arch Ophthalmol 1991; 109: 677-681
11. Gilbert CM, Owens SL, Smith PD et al. Long-term follow-up of central serous chorioretinopathy. Br J Ophthalmol 1984; 68: 815-820
12. Gill GN. The adrenal gland In: West JB (Hrsg). Best and Taylor's physiological basis of medical practice, edn 112. Baltimore: Williams and Wilkins, 1990: 820-830
13. Haimovici R, Gragoudas ES, Duker JS et al. Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids. Ophthalmology 1997; 104: 1653-1660
14. Haimovici R, Rumelt S, Melby J. Endocrine abnormalities in patients with central serous chorioretinopathy. Ophthalmology 2003; 110: 698-703
15. Haimovici R, Koh S, Gagnon DR. Risk factors for central serous chorioretinopathy: a case-control study. Ophthalmology 2004; 111: 244-249
16. Ie D, Yannuzzi LA, Spaide RF et al. Subretinal exudative deposits in central serous chorioretinopathy. Br J Ophthalmol 1993; 77: 349-353
17. Iida T, Spaide RF, Negrao SG et al. : Central serous chorioretinopathy after epidural coticosteroid injection. Am J Ophthalmol 2001; 132: 423-425
18. Jabs DA, Hanneken AM, Schachat AP et al. Choroidopathy in systemic lupus erythematosus. Arch Ophthalmol 1988; 106: 230-234
19. Karadimas P, Bouzas EA. Glucocorticoid use represents a risk factor for central serous chorioretinopathy: a prospective, case-control study. Graefes Arch Clin Exp Ophthalmol 2004; 242: 800-802
20. Lowder CY, Gutman FA, Zegarra H et al. Macular and paramacular detachment of the neurosensory retina associated with systemic diseases. Trans Am Ophthalmol Soc 1981; 79: 347-370
21. Polak BC, Baarsma GS, Snyers B. Diffuse retinal pigment epitheliopathy complicating systemic corticosteroid treatment. Br J Ophthalmol 1995; 79: 922-925
22. Pratt WB, Aronow L. The effects of glucocorticoids on protein and nucleic acid synthesis in mouse fibroblasts growing in vitro. J Biol Chem 1966; 241: 5244-5250
23. Quillen DA, Gass DM, Brod RD et al. Central serous chorioretinopthy in women. Ophthalmology 1996; 103: 72-79
24. Smith TJ. Dexamethasone regulation of glycosaminoglycan synthesis in cultured human skin fibroblasts. Similar effects of glucocorticoid and thyroid hormones. J Clin Invest 1984; 74: 2157-2163
25. Spitznas M. Pathogenesis of central serous retinopathy: a new working hypothesis. Graefes Arch Clin Exp Ophthalmology 1986; 224: 321-324
26. Tittl MK, Spaide RF, Wong D et al. Systemic findings associated with central serous chorioretinopathy. Am J Ophthalmol 1999; 128: 63-68
27. von Graefe A. Ueber centrale recidivierende retinitis. Graefes Arch Clin Exp Ophthalmol 1866; 12: 211-215
28. Wakakura M, Song E, Ishikawa S. Corticosteroid-induced central serous chorioretinopathy. Jpn J Ophthalmol 1997; 41: 180-185
29. Yoshioka H, Katsume Y, Akune H. Experimental central serous chorioretinopathy in monkey eyes: fluorescein angiographic findings. Ophthalmologica 1982; 185: 168-178